{"filing":{"accession_number":"0001213900-26-077134","cik":"0001937993","ticker":"CVKD","company_name":"Cadrenal Therapeutics, Inc.","form":"8-K","filing_date":"2026-07-10","report_date":null,"primary_document":"ea0297603-8k_cadrenal.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1937993/000121390026077134/ea0297603-8k_cadrenal.htm"},"events":[{"id":17316,"run_id":15495,"accession_number":"0001213900-26-077134","anchor_item_number":"5.02","event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"James J. Ferguson III, Chief Medical Officer, resigned effective July 31, 2026. The disclosure centers on the departure itself—the principal action is a named executive officer leaving his position. While the filing mentions ongoing separation negotiations, the core event is the resignation announcement, making exec_departure the most salient classification.","company_name":"Cadrenal Therapeutics, Inc.","ticker":"CVKD","filing_date":"2026-07-10","form":"8-K","submitted_at":null,"items":[{"id":15711,"accession_number":"0001213900-26-077134","item_number":"5.02","item_title":"Departure of Directors or Certain","event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"James J. Ferguson III, Chief Medical Officer, resigned effective July 31, 2026. The disclosure centers on the departure itself—the principal action is a named executive officer leaving his position. While the filing mentions ongoing separation negotiations, the core event is the resignation announcement, making exec_departure the most salient classification.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-10T20:06:51.766323+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":15711,"accession_number":"0001213900-26-077134","item_number":"5.02","item_title":"Departure of Directors or Certain","event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"James J. Ferguson III, Chief Medical Officer, resigned effective July 31, 2026. The disclosure centers on the departure itself—the principal action is a named executive officer leaving his position. While the filing mentions ongoing separation negotiations, the core event is the resignation announcement, making exec_departure the most salient classification.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-10T20:06:51.766323+00:00","company_name":"Cadrenal Therapeutics, Inc.","ticker":"CVKD","filing_date":"2026-07-10"}]}